Literature DB >> 19752756

CD167 acts as a novel costimulatory receptor in T-cell activation.

Nana Dang1, Jinsong Hu, Xinping Liu, Xia Li, Shaoping Ji, Wei Zhang, Jin Su, Fan Lu, Angang Yang, Hua Han, Wei Han, Boquan Jin, Libo Yao.   

Abstract

Optimal T-cell activation requires both an antigen-specific and a costimulatory signal. CD167 is a tyrosine kinase receptor for native type I collagen, its physiologic functions include matrix homeostasis and cell growth, adhesion, branching, and migration, but the specific role of CD167 in T cells has not yet been characterized. In this study, we found that CD167 expression on T cells was up-regulated after activation. Cooperation of CD167 engagement with suboptimal TCR/CD3 signals induced T-cell proliferation, enhanced expression of activation markers such as CD25 and CD69, elevated intracellular calcium mobilization and tyrosine phosphorylation, and introduced a bias toward a TH1/Tc1 immune response. Cooperation of CD167 engagement also enhanced mixed lymphocyte responses to alloantigens. Moreover, CD167 rapidly localized to the aggregated lipid rafts upon T-cell activation, this provided a molecular base for the signaling machinery of CD167. Together these findings, we demonstrate for the first time that CD167 could serve as a novel costimulatory receptor for T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752756     DOI: 10.1097/CJI.0b013e3181acea46

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  4 in total

Review 1.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

2.  Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.

Authors:  Hui Jing; Jingyuan Song; Junnian Zheng
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

3.  Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices.

Authors:  Philippe V Afonso; Colin P McCann; Senta M Kapnick; Carole A Parent
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

4.  Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway.

Authors:  Mohammed-Amine El Azreq; Maleck Kadiri; Marc Boisvert; Nathalie Pagé; Philippe A Tessier; Fawzi Aoudjit
Journal:  Oncotarget       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.